International Journal of Antimicrobial Agents
Volume 35, Issue 6 , Pages 566-572 , June 2010

Interaction of the antimicrobial peptide melimine with bacterial membranes

  • R. Rasul

      Affiliations

    • Institute for Eye Research, The University of New South Wales (UNSW), Sydney, NSW 2052, Australia
    • School of Optometry and Vision Science, The University of New South Wales (UNSW), Sydney, NSW 2052, Australia
    • ,
  • N. Cole

      Affiliations

    • Institute for Eye Research, The University of New South Wales (UNSW), Sydney, NSW 2052, Australia
    • School of Optometry and Vision Science, The University of New South Wales (UNSW), Sydney, NSW 2052, Australia
    • Vision Cooperative Research Centre, Sydney, NSW 2052, Australia
    • ,
  • D. Balasubramanian

      Affiliations

    • L.V. Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad, India
    • ,
  • R. Chen

      Affiliations

    • School of Chemistry, The University of New South Wales (UNSW), Sydney, NSW 2052, Australia
    • ,
  • N. Kumar

      Affiliations

    • School of Chemistry, The University of New South Wales (UNSW), Sydney, NSW 2052, Australia
    • ,
  • M.D.P. Willcox

      Affiliations

    • Institute for Eye Research, The University of New South Wales (UNSW), Sydney, NSW 2052, Australia
    • School of Optometry and Vision Science, The University of New South Wales (UNSW), Sydney, NSW 2052, Australia
    • Vision Cooperative Research Centre, Sydney, NSW 2052, Australia
    • Corresponding Author InformationCorresponding author. Present address: Institute for Eye Research, Level 4, North Wing, Rupert Myers Building, Gate 14, Barker Street, The University of New South Wales, Sydney, NSW 2052, Australia. Tel.: +61 2 9385 7412; fax: +61 2 9385 7401.

Received 2 November 2009 ,Accepted 4 February 2010.

References 

  1. Henderson DK, Levy SB, editors. Resistant organisms: global impact on continuum of care. International Congress and Symposium Series #220. New York, NY: Royal Society of Medicine; 1997.
  2. Marra AR, Pereira CA, Gales AC, Menezes LC, Cal RG, de Souza JM, et al. Bloodstream infections with metallo-β-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes. Antimicrob Agents Chemother. 2006;50:388–390
  3. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol. 1992;13:582–586
  4. Gordon YJ, Romanowski EG, McDermott AM. A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res. 2005;30:505–515
  5. Wang Z, Wang G. APD: the Antimicrobial Peptide Database. Nucleic Acids Res. 2004;32:D590–D592
  6. Zhang L, Rozek A, Hancock RE. Interaction of cationic antimicrobial peptides with model membranes. J Biol Chem. 2001;276:35714–35722
  7. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev. 2006;19:491–511
  8. Willcox MD, Hume EB, Aliwarga Y, Kumar N, Cole N. A novel cationic-peptide coating for the prevention of microbial colonization on contact lenses. J Appl Microbiol. 2008;105:1817–1825
  9. Chen R, Cole N, Willcox MD, Park J, Rasul R, Carter E, et al. Synthesis, characterization and in vitro activity of a surface-attached antimicrobial cationic peptide. Biofouling. 2009;25:517–524
  10. Lam YH, Wassall SR, Morton CJ, Smith R, Separovic F. Solid-state NMR structure determination of melittin in a lipid environment. Biophys J. 2001;81:2752–2761
  11. Matsuzaki K, Sugishita K, Harada M, Fujii N, Miyajima K. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim Biophys Acta. 1997;1327:119–130
  12. Kempf C, Klausner RD, Weinstein JN, Van Renswoude J, Pincus M, Blumenthal R. Voltage-dependent trans-bilayer orientation of melittin. J Biol Chem. 1982;257:2469–2476
  13. Mousli M, Bueb JL, Bronner C, Rouot B, Landry Y. G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci. 1990;11:358–362
  14. Ebert G, Zolzer U, Nishi N. Solubilization and conformation of protamines in reverse micelles. Prog Colloid Polym Sci. 1990;83:181–187
  15. Aspedon A, Groisman EA. The antibacterial action of protamine: evidence for disruption of cytoplasmic membrane energization in Salmonella typhimurium. Microbiology. 1996;142:3389–3397
  16. Abrunhosa F, Faria S, Gomes P, Tomaz I, Pessoa JC, Andreu D, et al. Interaction and lipid-induced conformation of two cecropin–melittin hybrid peptides depend on peptide and membrane composition. J Phys Chem B. 2005;109:17311–17319
  17. Ruhr E, Sahl HG. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob Agents Chemother. 1985;27:841–845
  18. Friedrich CL, Moyles D, Beveridge TJ, Hancock RE. Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria. Antimicrob Agents Chemother. 2000;44:2086–2092
  19. Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother. 1998;42:2206–2214
  20. Bucki R, Pastore JJ, Randhawa P, Vegners R, Weiner DJ, Janmey PA. Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin. Antimicrob Agents Chemother. 2004;48:1526–1533
  21. Friedrich C, Scott MG, Karunaratne N, Yan H, Hancock RE. Salt-resistant α-helical cationic antimicrobial peptides. Antimicrob Agents Chemother. 1999;43:1542–1548
  22. Bengoechea JA, Diaz R, Moriyon I. Outer membrane differences between pathogenic and environmental Yersinia enterocolitica biogroups probed with hydrophobic permeants and polycationic peptides. Infect Immun. 1996;64:4891–4899
  23. Wu M, Maier E, Benz R, Hancock RE. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry. 1999;38:7235–7242
  24. Rifkind JM. Helix–coil transition of poly-l-arginine: a comparison with other basic polypeptides. Biopolymers. 1969;8:685–688
  25. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev. 1992;56:395–411
  26. Lee KH, Fitton JE, Wuthrich K. Nuclear magnetic resonance investigation of the conformation of δ-haemolysin bound to dodecylphosphocholine micelles. Biochim Biophys Acta. 1987;911:144–153
  27. Orlando JS, Ornelles DA. An arginine-faced amphipathic α helix is required for adenovirus type 5 E4orf6 protein function. J Virol. 1999;73:4600–4610
  28. Raghuraman H, Chattopadhyay A. Interaction of melittin with membrane cholesterol: a fluorescence approach. Biophys J. 2004;87:2419–2432
  29. Verdon J, Girardin N, Lacombe C, Berjeaud JM, Hechard Y. δ-Hemolysin, an update on a membrane-interacting peptide. Peptides. 2009;30:817–823
  30. Groisman EA. Bacterial responses to host-defense peptides. Trends Microbiol. 1996;4:127–128[discussion 128–9]
  31. Zhang L, Dhillon P, Yan H, Farmer S, Hancock RE. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2000;44:3317–3321
  32. Jia Z. Protein phosphatases: structures and implications. Biochem Cell Biol. 1997;75:17–26
  33. Taubes G. The bacteria fight back. Science. 2008;321:356–361

PII: S0924-8579(10)00079-8

doi: 10.1016/j.ijantimicag.2010.02.005

International Journal of Antimicrobial Agents
Volume 35, Issue 6 , Pages 566-572 , June 2010

Article Tools

* Image Usage & Resolution